Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial

Kris M. Mahadeo, Robert A. Baiocchi, Amer Beitinjaneh, Sridhar Chaganti, Sylvain Choquet, Daan Dierickx, Rajani Dinavahi, Xinyuan Duan, Laurence Gamelin, Armin Ghobadi, Norma Guzmán‐Becerra, Manher Joshi, Aditi Mehta, Willis H. Navarro, Sarah Nikiforow, Richard J. O’Reilly, Ran Reshef, Fiona Ruiz, Tassja J. Spindler, Susan E. Prockop